SkyWater (SKYT): CFO Executes Option Exercise and Market Sale on 09/26/2025
Rhea-AI Filing Summary
SkyWater Technology (SKYT) CFO Steve Manko executed and disclosed option exercise and share sales under a Rule 10b5-1 plan on 09/26/2025. He exercised 19,544 options with a $14 exercise price, resulting in acquisition of 19,544 common shares. On the same date he sold 60,829 shares at a weighted-average price of $17.40 (individual sale prices ranged from $17.25 to $18.07). The filing reports beneficial ownership of 387,951 shares after the option exercise and 327,122 shares after the sales. Both transactions were effected pursuant to a Rule 10b5-1 trading plan entered March 14, 2025. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating pre-established, compliant trading arrangements
- Clear disclosure of quantities and weighted-average sale price (sales at $17.25–$18.07; weighted average $17.40)
- Form 4 includes required procedural elements such as attorney-in-fact signature and exercise/sale details
Negative
- CFO reduced beneficial ownership by 60,829 shares (from 387,951 to 327,122) which may be viewed negatively by some investors
- Large insider sale on a single date could attract market attention despite being pre-planned
Insights
TL;DR: Insider exercised options and sold shares under a pre-established 10b5-1 plan; disclosure is routine and compliant.
The transactions combine a stock-option exercise and a subsequent open-market sale executed on 09/26/2025 under a Rule 10b5-1 plan dated March 14, 2025. The exercise converted 19,544 options at $14 into the same number of shares, increasing reported holdings to 387,951, followed by sales of 60,829 shares at a weighted average of $17.40 reducing holdings to 327,122. From an analytical perspective this represents a liquidity event by the CFO executed under an established plan, which reduces insider stake but follows recognized compliance mechanisms and provides clear price and quantity disclosure.
TL;DR: Transactions follow formal Rule 10b5-1 procedures, indicating pre-planned disposition rather than opportunistic trading.
The filing explicitly states both the option exercise and the share sale were effected pursuant to a Rule 10b5-1 trading plan entered March 14, 2025, which supports compliance with insider trading rules. The disclosure includes the weighted-average sale price range and notes option vesting schedule language for the original grant. Signature by an attorney-in-fact is included, meeting procedural requirements. The filing does not report any derivative holdings remaining following the reported exercise.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Options to Acquire Common Stock | 19,544 | $0.00 | -- |
| Exercise | Common Stock | 19,544 | $14.00 | $274K |
| Sale | Common Stock | 60,829 | $17.40 | $1.06M |
Footnotes (1)
- The reported option exercise was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 14, 2025. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 14, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.25 to $18.07, inclusive. The options vest ratably on each of the first, second, third and fourth anniversaries of the grant date contingent on the reporting person's continuation in service on each applicable vesting date.
